Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial

Adam Christian Vilmar, Eric Santoni-Rugiu, Jens Benn Sørensen

    36 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial'. Sammen danner de et unikt fingeraftryk.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science